Skip to main content
Contact Us
Subscribe
E-Edition
55°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Assembly Biosciences
(NQ:
ASMB
)
16.05
-0.27 (-1.65%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Assembly Biosciences
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 21, 2024
Via
Benzinga
Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates
November 07, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 16, 2024
Via
Benzinga
Assembly Biosciences' Investigational Herpes Treatment Shows Antiviral Efficacy, Safety In Healthy Participants
September 23, 2024
Assembly Biosciences reported interim results from its Phase 1a study of ABI-5366, a long-acting HSV inhibitor for recurrent genital herpes. The drug showed a favorable safety profile and achieved...
Via
Benzinga
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366
September 23, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
ASMB Stock Earnings: Assembly Biosciences Beats EPS, Beats Revenue for Q2 2024
August 09, 2024
ASMB stock results show that Assembly Biosciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates
August 08, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop
July 15, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Insiders Buying American Software And 2 Other Stocks
July 09, 2024
Via
Benzinga
Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection
June 18, 2024
– Phase 1b study will evaluate safety, pharmacokinetic and efficacy endpoints in participants with chronic hepatitis B virus infection with interim data expected by the end of 2024 –
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Assembly Biosciences Announces $12.6 Million in Equity Financings
June 17, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366
June 10, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
June 05, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024
May 22, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q1 2024
May 13, 2024
ASMB stock results show that Assembly Biosciences beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
May 08, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q4 2023
March 28, 2024
ASMB stock results show that Assembly Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
March 28, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
ASMB Stock Earnings: Assembly Biosciences Misses EPS for Q2 2023
March 25, 2024
ASMB stock results show that Assembly Biosciences missed analyst estimates for earnings per share the second quarter of 2023.
Via
InvestorPlace
Assembly Biosciences Announces Effective Date of Reverse Stock Split
February 08, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Assembly Biosciences Provides Anticipated Development Milestones for 2024
January 04, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
December 12, 2023
Shares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
November 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 22, 2023
Via
Benzinga
Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 10, 2023
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®
November 10, 2023
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates
November 08, 2023
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer
November 08, 2023
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.